Your Messages Inbox
Your Article Summary
See Latest ArticlesSanofi-aventis converts its Vitry-sur-Seine Industrial Facility to Biotechnologies
Sanofi-aventis, 05/06/09
Sanofi-aventis officially launched the BIOLAUNCH project at its Vitry-sur-Seine (France) pharmaceuticals production site, in the presence of Luc Chatel, Secretary of State for Industry and Consumption at the Ministry for the Economy, Industry and Employment, Spokesman for the Government, Christopher A. Viehbacher, Chief Executive Officer of sanofi-aventis, Philippe Luscan, Senior-Vice President, Industrial Affairs, sanofi-aventis and Christian Lajoux, Chief Executive Officer of sanofi-aventis France. BIOLAUNCH is a major operation for sanofi-aventis in France.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
What Makes a Generic Medication Generic?
Journal of Psychosocial Nursing and Mental Health Services, 12/18/09
Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09
Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09
Today in Medical Devices/Products...keeping you current
Receive free subspecialty "5-minute updates" via email
Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies
Covidien, 12/18/09
Eslicarbazepine: A novel antiepileptic agent designed for improved efficacy and safety
Formulary , 12/16/09
FDA Advisory Committee Supports Use of Aztreonam for Inhalation Solution for Patients with Cystic Fibrosis
Gilead, 12/14/09
Article Search
Sponsor